-
Intrapatient 16a-[18F]Fluoro-17b-Estradiol PET Heterogeneity as a Prognostic Factor for Endocrine Therapy Response and Survival in Patients with Estrogen Receptor–Positive Metastatic Breast Cancer
van Geel, J. J. L., Moustaquim, J., Boers, J., Elias, S. G., Smeets, E. M. M., Knip, J. J., Glaudemans, A. W. J. M., de Vries, E. F. J., Hospers, G. A. P., van Kruchten, M., Stokkel, M., Oprea-Lager, D. E., Menke-van der Houven van Oordt, W. C., de Vries, E. G. E. & IMPACT-Metastatic Breast Consortium, 1 Feb 2025, In: Journal of nuclear medicine. 66, 2, p. 194-200 7 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial
Rediti, M., Fimereli, D., Mileva, M., Wimana, Z. N., Venet, D., Flamen, P., Guiot, T., de Vries, E. G. E., Schröder, C. P., Menke-van der Houven van Oordt, C. W., Maetens, M., Majjaj, S., Larsimont, D., Rothé, F., Sotiriou, C. & Gebhart, G. R., 1 Jan 2025, In: Clinical Cancer Research. 31, 1, p. 110-121 12 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)
Mileva, M., de Vries, E. G. E., Guiot, T., Wimana, Z., Deleu, A.-L., Schröder, C. P., Lefebvre, Y., Paesmans, M., Stroobants, S., Huizing, M., Aftimos, P., Tol, J., Van der Graaf, W. T. A., Oyen, W. J. G., Vugts, D. J., Menke-van der Houven van Oordt, C. W., Brouwers, A. H., Piccart-Gebhart, M., Flamen, P. & Gebhart, G., Dec 2024, In: NPJ Breast Cancer. 10, 1, p. 4 4.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
